Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- Check3 days agoChange DetectedUpdated core content with new study status and contacts/locations dated 2025-10-09/2025-10-08, replacing the prior 2025-09-16 entry.SummaryDifference0.8%
- Check10 days agoChange DetectedSummary: The page adds a government-operating-status notice and new version tag (v3.2.0) while removing the old version tag (v3.1.0). This signals an update to the page’s operating status information and the release version.SummaryDifference11%
- Check17 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%
- Check24 days agoChange DetectedExpanded clinical trial record with fuller metadata and a new date; deletions remove an older, shorter entry.SummaryDifference3%
- Check31 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. This is a small UI/metadata change with no impact on core content.SummaryDifference0.7%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%
Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.